Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study

Table 5 OST and injecting drug use behaviour

	Baseline whole cohort	Baseline for both measures cohort	Follow-up
	N = 44	N = 30	N = 30
Current OST	25 (57)	17 (57)	20 (67)
Current methadone patients
Years taking methadone	N = 23	N = 16	N = 17
Median* [Q1, Q3]	2 [0, 5]	1 [0, 2]	1 [0, 3]
Current dose (ml)	N = 23		N = 15
Median [Q1, Q3]	70 [50, 100]	78 [50, 98]	60 [45, 90]
Current buprenorphine patients
Years taking buprenorphine	N = 3	N = 2	N = 3
Median (Min, Max)	1 (1, 2)	1 (1, 1)	0 (0, 1)

	N = 44	N = 30	N = 30
Injected in the past month	16 (36)	10 (33)	2 (7)
If yes, on how many days did they inject	N = 10	N = 5	N = 1
Median [Q1, Q3]	1.5 [1, 30]	1 [1, 3]	30
Overdose in the last month	2 (5)	2 (7)	0 (–)

Cells are n and (%) except for rows with days which summarises median [25th, 75th centile] years of use. *0 years implies less than 1 year of duration

ISSN: 1477-7517